These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 33493983)

  • 1. Mechanisms of thrombosis and cardiovascular complications in COVID-19.
    Page EM; Ariëns RAS
    Thromb Res; 2021 Apr; 200():1-8. PubMed ID: 33493983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.
    Obi AT; Barnes GD; Napolitano LM; Henke PK; Wakefield TW
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):23-35. PubMed ID: 32916371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A COVID-Positive 52-Year-Old Man Presented With Venous Thromboembolism and Disseminated Intravascular Coagulation Following Johnson & Johnson Vaccination: A Case-Study.
    Shazley O; Alshazley M
    Cureus; 2021 Jul; 13(7):e16383. PubMed ID: 34408937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
    Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
    Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management.
    Manolis AS; Manolis TA; Manolis AA; Papatheou D; Melita H
    J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):12-24. PubMed ID: 32924567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the COVID-19 thrombotic catastrophe complement-connected?
    Conway EM; Pryzdial ELG
    J Thromb Haemost; 2020 Nov; 18(11):2812-2822. PubMed ID: 32762081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The coagulopathy, endotheliopathy, and vasculitis of COVID-19.
    Iba T; Connors JM; Levy JH
    Inflamm Res; 2020 Dec; 69(12):1181-1189. PubMed ID: 32918567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic Complications of COVID-19 Infection: A Review.
    Castro RA; Frishman WH
    Cardiol Rev; 2021; 29(1):43-47. PubMed ID: 32947478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracardiac Prothrombotic Effects of COVID-19.
    Kankaria R; Sanina C; Gabr M; Wiley J; Bortnick AE
    Heart Fail Clin; 2023 Apr; 19(2):213-220. PubMed ID: 36863813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulants for people hospitalised with COVID-19.
    Flumignan RL; Civile VT; Tinôco JDS; Pascoal PI; Areias LL; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013739. PubMed ID: 35244208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications.
    McFadyen JD; Stevens H; Peter K
    Circ Res; 2020 Jul; 127(4):571-587. PubMed ID: 32586214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant Cerebral Ischemia in A COVID-19 Infected Patient: Case Review and Histopathological Findings.
    Patel SD; Kollar R; Troy P; Song X; Khaled M; Parra A; Pervez M
    J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105231. PubMed ID: 33066910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 versus HIT hypercoagulability.
    Warkentin TE; Kaatz S
    Thromb Res; 2020 Dec; 196():38-51. PubMed ID: 32841919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulopathy of Coronavirus Disease 2019.
    Iba T; Levy JH; Levi M; Connors JM; Thachil J
    Crit Care Med; 2020 Sep; 48(9):1358-1364. PubMed ID: 32467443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature review.
    Hsiao PJ; Wu KL; Chen YC; Chen YL; Wang RL; Wu KA; Chan JS; Chiu CC; Huang LY; Shyu HY; Kao YH; Chuu CP
    Clin Chim Acta; 2022 Apr; 529():42-45. PubMed ID: 35167842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019.
    Thondapu V; Montes D; Rosovsky R; Dua A; McDermott S; Lu MT; Ghoshhajra B; Hoffmann U; Gerhard-Herman MD; Hedgire S
    J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):835-844.e4. PubMed ID: 33188961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic complications of COVID-19.
    Avila J; Long B; Holladay D; Gottlieb M
    Am J Emerg Med; 2021 Jan; 39():213-218. PubMed ID: 33036855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and thrombosis: From bench to bedside.
    Ali MAM; Spinler SA
    Trends Cardiovasc Med; 2021 Apr; 31(3):143-160. PubMed ID: 33338635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium.
    Gorog DA; Storey RF; Gurbel PA; Tantry US; Berger JS; Chan MY; Duerschmied D; Smyth SS; Parker WAE; Ajjan RA; Vilahur G; Badimon L; Berg JMT; Cate HT; Peyvandi F; Wang TT; Becker RC
    Nat Rev Cardiol; 2022 Jul; 19(7):475-495. PubMed ID: 35027697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.